+499.5%
MRNA vs ALC
-10.2%
+509.6%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ALC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -2.2% | 0.0% | -0.4% |
| 7D | +5.5% | -2.1% | +7.6% | +7.3% |
| 30D | +158.7% | -0.1% | +158.8% | +163.9% |
| 3M | +182.1% | +5.9% | +176.2% | +176.4% |
| 6M | +151.8% | -15.9% | +167.7% | +208.6% |
| YTD | +393.6% | -10.1% | +403.7% | +457.9% |
| 1Y | +499.5% | -10.2% | +509.7% | +609.9% |
| All | +499.5% | -10.2% | +509.6% | +609.9% |
Cumulative growth
Daily Returns
Daily percentage return beside ALC.
Daily Out/Under-Performance
Portfolio return minus ALC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ALC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ALC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling